摘要:
Provided is an ink jet recording method including primarily applying a resin ink containing resin components to a recording medium to form a first resin ink layer, and secondarily applying the resin ink to the first resin ink layer to form a second resin ink layer, to thereby form a resin ink layer, wherein each of the primary applying process and the secondary applying process includes drying the applied resin ink.
摘要:
A communication control method executed in a multi-hop cellular network including at least one gateway and a plurality of radio base stations includes: a first radio base station performing radio resource management and movement management concerning a radio mobile station requesting, when the first radio base station determines it is necessary to switch a connection destination of the radio mobile station, a second radio base station at a handover destination to perform handover processing and instructing the radio mobile station (a handover execution mobile station) to perform handover to the second radio base station; and the second radio base station determining, based on the number of times of transfer until a signal transmitted from the first radio base station reaches the own station, whether to change the radio base station that performs the radio resource management and the movement management concerning the handover execution mobile station.
摘要:
The ink jet recording method is an ink jet recording method used in a recording apparatus including a white ink containing a white color material, a resin ink containing a resin, and a glitter ink containing a glitter pigment, and a head for recording using the white ink, the resin ink, and the glitter ink, the method including firstly forming a white ink layer on a recording medium, secondly forming a resin ink layer on the white ink layer, and thirdly forming the glitter ink layer on the white ink layer.
摘要:
[Object] There is provided an inkjet recording method in which two liquids are printed and which can perform inkjet ejection, in which the inkjet recording method provides a high-quality image using a reaction liquid having excellent storage stability, ejection stability, and recoverability from clogging on a recording medium having an absorbing layer of a paper support with low water absorption, the image having excellent abrasion resistance.[Solving Means] An inkjet recording method includes the step of attaching a reaction liquid and an ink composition to a recording medium to perform printing, in which the recording medium has an absorbing layer of a paper support in which the amount of water absorbed within 30 msec1/2 from the start of contact in the Bristow method is 30 ml/m2 or less, the reaction liquid contains a polyether-modified polysiloxane-based compound and at least one selected from a polyvalent metal salt, polyallylamine, and polyallylamine derivatives, and the ink composition contains water, a colorant, and resin emulsion particles.
摘要翻译:提供一种喷墨记录方法,其中两种液体被印刷并且可以执行喷墨喷射,其中喷墨记录方法使用具有优异的储存稳定性,喷射稳定性和可回收性的反应液提供高质量的图像 在具有低吸水性的纸支架的吸收层的记录介质上堵塞,该图像具有优异的耐磨性。 [解决方案]喷墨记录方法包括将反应液和油墨组合物附着到记录介质上以进行打印的步骤,其中记录介质具有纸支持体的吸收层,其中吸收的水量在30 来自Bristow方法的接触开始的msec1 / 2为30ml / m 2以下,反应液含有聚醚改性聚硅氧烷类化合物和选自多价金属盐,聚烯丙基胺和聚烯丙胺衍生物中的至少一种, 油墨组合物含有水,着色剂和树脂乳液颗粒。
摘要:
A cushioning clip for receiving a movement of a movable member approaching a stationary member, including a cushioning part, for absorbing an impact force, and a mounting part for mounting the cushioning part to the stationary member. The cushioning part is formed of a flexible material exhibiting elasticity. The mounting part is formed of a rigid material exhibiting a predetermined rigidity. A hollow part is formed in the cushioning part. An inner wall of the hollow part is formed almost perpendicularly to the stationary member, and an apex part on a distal end side of the inner wall is flexed inwardly.
摘要:
An ink set includes: at least one black ink composition that contains at least a self-dispersing pigment and a resin emulsion; and at least one color ink composition that contains at least an organic pigment covered with water-insoluble polymer and a resin emulsion.
摘要:
An ink composition, a recording medium or printed matter containing a compound expressed by General Formula 1 The compound has a weight reduction after 1 hour at 60°C. of no more than 1%. This makes it possible to provide the ink composition, a recording medium, printed matter, and an ink jet recording method wherein a light resistance of the printed matter is excellent, there is no ink clogging, and a high-quality image with almost no yellowing of the printed matter can be obtained.
摘要:
The ink composition of the present invention contains a coloring agent, water, a water-soluble organic solvent which is a liquid at least at temperatures of 40° C. or less, and which has a solubility of 1 wt % or greater with respect to water at a temperature of 20° C., and a saturation vapor pressure of 1.7 Pa or less at a temperature of 20° C. (with said organic solvent being contained in the ink composition at the rate of 10 to 35 wt %), and one or more amidine type compounds. As a result, the present invention provides an ink composition, a recording medium, recorded matter and an ink jet recording method that make it possible to obtain images with a high image quality which are superior in terms of the gas resistance of the recorded matter.
摘要:
The present invention relates to a compound represented by general formula (I) or a pharmaceutically acceptable salt or ester thereof: ##STR1## [wherein each of ##STR2## is an aryl group or an aromatic heterocyclic group; A.sup.1 is a C.sub.1-6 chain hydrocarbon group or a group represented by --A.sup.1a --W.sup.1 --A.sup.1b -- (wherein W.sup.1 is an oxygen atom, a sulfur atom, an ethynylene group, a cyclopropylene group or a group represented by --NR.sup.W --); A.sup.2 is a C.sub.1-8 chain hydrocarbon group; R.sup.1 is a lower alkyl group, a lower alkenyl group, a lower alkoxy group, a carboxyl group, a lower alkoxycarbonyl group, a carbamoyl group, a lower alkylcarbamoyl group, a group represented by R.sup.a COO-- (wherein R.sup.a is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or by R.sup.b CONR.sup.c -- (wherein R.sup.b is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or an alicyclic group; R.sup.2 is a lower alkyl group; and each of X and Y is an oxygen atom, a sulfur atom, a carbonyl group, a group represented by --CHR.sup.d -- or by --NR.sup.e --, or X and Y together represent a vinylene group or an ethynylene group, provided that when one of X and Y is an oxygen atom, a sulfur atom or group represented by --NR.sup.e --, the other is a carbonyl group or a group represented by --CHR.sup.d --] and an antitumor agent comprising it as an active ingredient.
摘要:
The present invention relates to a compound of the formula (I): ##STR1## wherein Ar.sup.1, Ar.sup.2, Ar.sup.3 and Ar.sup.4 represent an aryl group or a heteroaromatic ring group; A represents a hydrocarbon group which may be substituted; X and Y represent an oxygen atom, a sulfur atom, a carbonyl group or a group of the formula --CHR.sup.a -- (wherein R.sup.a is a hydrogen atom or a lower alkyl group) or --NR.sup.b -- (wherein R.sup.b is a hydrogen atom or a lower alkyl group), or X and Y together represent a vinylene group or an ethynylene group; R.sup.1, R.sup.2, R.sup.3, R.sup.8 and R.sup.9 represent a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group or a lower alkoxy group; R.sup.4 and R.sup.5 represent a hydrogen atom, a halogen atom, a hydroxyl group, an amino group, a nitro group, a cyano group, a carboxyl group, a lower alkoxycarbonyl group, a carbamoyl group, a lower alkylcarbamoyl group, a lower alkyl group, a lower hydroxyalkyl group, a lower fluoroalkyl group or a lower alkoxy group; R.sup.6 is a lower alkyl group; and R.sup.7 is a hydrogen atom or a lower alkyl group, provided that when one of X and Y is an oxygen atom, a sulfur atom or a group of the formula --NR.sup.b --, the other is a carbonyl group or a group of the formula --CHR.sup.a --, its pharmaceutically acceptable salt or ester, and an antitumor agent containing it as an active ingredient.